Wan, Yin
Wang, Jianxin
O’Connor, Thomas N.
Kumarasamy, Vishnu
Sanidas, Ioannis
Abrams, Scott I.
Witkiewicz, Agnieszka K.
Knudsen, Erik S.
Funding for this research was provided by:
National Cancer Institute (CA247362, CA247362)
Article History
Received: 19 March 2025
Accepted: 17 October 2025
First Online: 1 December 2025
Competing interests
: ESK has sponsored research funded by Blueprint Medicines and Bristol Myers Squibb and is a member of the Cancer Cell Cycles-LLC consulting enterprise. AKW has sponsored research funded by Blueprint Medicines and Bristol Myers Squibb. All other authors declare no potential conflicts of interest.